Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 03, 2015 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference

BERKELEY HEIGHTS, N.J., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral...
January 06, 2015 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals to Present at the Biotech Showcase(TM) 2015 Conference

BERKELEY HEIGHTS, N.J., Jan. 6, 2015 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) "Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies...
December 16, 2014 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Announces Enrollment of 486 Patients, DSMB Recommendations and That the Seamless Phase 3 Trial of Sapacitabine in AML Will Continue to Final Analysis

- DSMB determined that the planned futility boundary has been crossed; but saw no reason for patients to discontinue from study - - Conference Call Scheduled December 16, 2014 at 9:00 a.m. EST...
November 11, 2014 16:05 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Reports Third Quarter 2014 Financial Results

BERKELEY HEIGHTS, N.J., Nov. 11, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral...
November 04, 2014 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals to Release 2014 Third Quarter Financial Results

BERKELEY HEIGHTS, N.J., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral...
October 09, 2014 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Announces Data Safety Monitoring Board Recommendation to Continue the Seamless Phase 3 Trial of Sapacitabine in AML

BERKELEY HEIGHTS, N.J., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies...
September 19, 2014 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel to Present at BioCentury's Newsmakers in the Biotech Industry Conference

BERKELEY HEIGHTS, N.J., Sept. 19, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral...
September 18, 2014 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel's CYC065 CDK Inhibitor Demonstrates Therapeutic Potential in Acute Leukemias With Mixed Lineage Leukemia (MLL) Rearrangements

BERKELEY HEIGHTS, N.J., Sept. 18, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), today announced the presentation of preclinical...
September 11, 2014 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Appoints Samuel L. Barker, Ph.D., to Board of Directors

BERKELEY HEIGHTS, N.J., Sept. 11, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today the appointment of Samuel L....
September 10, 2014 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Announces Abstract Selected for Presentation at Society of Hematologic Oncology Annual Meeting

BERKELEY HEIGHTS, N.J., Sept. 10, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral...